Looking at the right hand graph it seems that as peoples androgel 1% runs out they are replacing it with either androgel 1.62% or axiron (with axiron gaining 12% to androgel's 7%).
If this keeps up along the same trend (gradually phasing out the androgel 1%) it will mean a further increase in axiron of 12/19*50% = 31.6% taking it's market share to 43%. (Admittedly axiron was released a litle earlier than the androgel 1.62% but it appears to have a slightly steeper curve anyway).
It may also pick up a few percent from the other brands.
All just speculation but it is looking extremely positive and as you say animal health products to be approved soon also.
ACR Price at posting:
$3.48 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)